COMPANY
Clinical Phase 1
Keywords: antibody oncology advanced solid tumors Ovarian Cancer Endometrial Cancer Cholangiocarcinoma CNS Tumor Breast Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma Ovarian Carcinosarcoma PHST001
Location: Redwood City, CA · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: A Study of PHST001 in Advanced Solid Tumors source ↗
Upcoming milestones
- 2029-04 (ESTIMATED) · Phase 1 · A Study of PHST001 in Advanced Solid Tumors · NCT06840886
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06840886 | A Study of PHST001 in Advanced Solid Tumors | Phase 1 | Recruiting | Mar 31, 2025 | 2029-04 (estimated) |
Raises and investors new
Form D raises come from the company’s own SEC filing (last 2 years).
- InvestorListed in the portfolio of ARCH Venture Partners (captured Oct 12, 2026). portfolio page ↗
